New heteroleptic Zn(II) and Cu(II) complexes with quercetine and N^N ligands
Sign Up to like & getrecommendations! Published in 2018 at "Polyhedron"
DOI: 10.1016/j.poly.2018.03.016
Abstract: Abstract New heteroleptic complexes having the general formula (N^N)MQCl, where N^N = 2,2′-bipyridine or 1,10-phenanthroline, M = Cu(II) or Zn(II) and Q = quercetin were synthesized and characterized by analytical and spectroscopic methods. The complexes are more sensitive to air oxygen… read more here.
Keywords: quercetine ligands; heteroleptic complexes; complexes quercetine; new heteroleptic ... See more keywords
New Heteroleptic bis-(diphenylphosphino)ethane appended dialkyldithiophosphatecobalt(III) cations: Apt electrocatalysts for heterogeneous Oxygen Evolution Reaction and homogeneous Hydrogen Evolution Reaction
Sign Up to like & getrecommendations! Published in 2024 at "New Journal of Chemistry"
DOI: 10.1039/d4nj02358g
Abstract: Two new heteroleptic cobalt(III)diakyldithiophosphate complex cations with 1,2-bis(diphenylphosphino)ethane (dppe) ancillary ligand having formula [Co{S2P(OR)2}2(dppe)](B(C6H5)4) (R = -C2H5 (Co-Et); -CH(CH3)2 (Co-Pr)) have been synthesized and characterized spectroscopically as well as by... read more here.
Keywords: evolution; new heteroleptic; evolution reaction; diphenylphosphino ethane ... See more keywords
A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel
Sign Up to like & getrecommendations! Published in 2024 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics16121610
Abstract: Background/Objectives: Triple-negative breast cancer (TNBC) is the most challenging molecular subtype of breast cancer (BC) in clinical practice, associated with a worse prognosis due to limited treatment strategies and its insensitivity to conventional drugs. Zinc… read more here.
Keywords: breast cancer; breast; new heteroleptic; negative breast ... See more keywords